Literature DB >> 10229224

Towards the global elimination of trachoma.

H Taylor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10229224     DOI： 10.1038/8376

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  6 in total

1.  Can we eliminate trachoma?

Authors:  T Lietman; A Fry
Journal:  Br J Ophthalmol       Date:  2001-04       Impact factor: 4.638

2.  What more is there to learn about trachoma?

Authors:  M Melese; W Alemayehu; B Gaynor; E Yi; J P Whitcher; T M Lietman
Journal:  Br J Ophthalmol       Date:  2003-05       Impact factor: 4.638

3.  Trachoma, antibiotics and randomised controlled trials.

Authors:  B Shapiro; K Dickersin; T Lietman
Journal:  Br J Ophthalmol       Date:  2006-12       Impact factor: 4.638

4.  Trachoma decline and widespread use of antimicrobial drugs.

Authors:  Jaya D Chidambaram; Mariko Bird; Vivian Schiedler; Alicia M Fry; Travis Porco; Ramesh C Bhatta; Hem Jha; J S P Chaudary; Bruce Gaynor; Elizabeth Yi; John P Whitcher; Susie Osaki-Holm; Thomas M Lietman
Journal:  Emerg Infect Dis       Date:  2004-11       Impact factor: 6.883

5.  Reduction and return of infectious trachoma in severely affected communities in Ethiopia.

Authors:  Takele Lakew; Jenafir House; Kevin C Hong; Elizabeth Yi; Wondu Alemayehu; Muluken Melese; Zhaoxia Zhou; Kathryn Ray; Stephanie Chin; Emmanuel Romero; Jeremy Keenan; John P Whitcher; Bruce D Gaynor; Thomas M Lietman
Journal:  PLoS Negl Trop Dis       Date:  2009-02-03

6.  Active trachoma two years after three rounds of azithromycin mass treatment in Cheha District Gurage Zone, Southern Ethiopia.

Authors:  Fisseha Admassu; Samson Bayu; Abebe Bejiga; Bemnet Amare
Journal:  BMC Pediatr       Date:  2013-12-01       Impact factor: 2.125
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.